3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with raffinose in 1 studies
Studies (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Trials (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Recent Studies (post-2010) (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Studies (raffinose) | Trials (raffinose) | Recent Studies (post-2010) (raffinose) |
---|---|---|---|---|---|
36 | 1 | 1 | 2,785 | 106 | 517 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belzer, FO; Saunder, A; Schilling, M; Southard, JH | 1 |
1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and raffinose
Article | Year |
---|---|
Long-term renal preservation and prevention of acute tubular necrosis by inhibition of arachidonate metabolism.
Topics: Adenosine; Allopurinol; Animals; Arachidonic Acid; Aspirin; Benzofurans; Dogs; Enzyme Inhibitors; Female; Glutathione; Ibuprofen; Imidazoles; Insulin; Kidney Transplantation; Kidney Tubular Necrosis, Acute; Kidney Tubules; Leukotriene Antagonists; Leukotrienes; Organ Preservation; Organ Preservation Solutions; Pyridines; Raffinose; Thromboxane-A Synthase | 1995 |